TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

OPENPICHIA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

OPENPICHIA

ST13

US500000097867321

Classe

5, 42

Pedido

97867321

Registro

7773262

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

24

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 42

Data de depósito

31/03/2023

Data de registro

29/04/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

29/04/2025

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Foreign priority

Código do desenho

4

Tipo de titular

99

Localização do titular

Gent, BE

Examinador

CORWIN, KEVIN SCOTT

Unidade examinadora

M30

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

V. V. (pessoa física)

Representantes

Clifford D. Hyra FRESH IP PLC

Classificação técnica

Classes Nice

Classe 5Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations and substances, namely, pharmaceutical preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Pharmaceutical preparations and substances, namely, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals, and preparations in the nature of medicated wheat-free and gluten-free pasta, crackers for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Medical preparations and substances, namely, fungal preparations in the nature of fungal medications for medical purposes, probiotic preparations for medical use, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Veterinary preparations and substances, namely, fungal preparations in the nature of fungal medications for veterinary purposes; Veterinary preparations in the nature of veterinary pharmaceutical preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Biologicals preparations for medical and veterinary use, namely, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Diagnostic and therapeutic preparations for pharmaceutical, medical and veterinary purposes, namely, diagnostic preparations for veterinary and medical use, pharmaceutical preparations and biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Cultures for pharmaceutical, medical and veterinary purposes, namely, diagnostic media for fungal cultures and cultures of microorganisms, all for medical or veterinary purposes; Preparations and substances for use in drug discovery, namely, sterilizing preparations, growth media preparations in the nature of cell growth media for growing cells for medical and veterinary purposes, and reagents and media for medical and veterinary diagnostic purposes, namely, such media and reagents serving as inoculate, clinical medical reagents, and diagnostic reagents

Classe 42

Science and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, biotechnology, the food and animal feed industries, veterinary science, manufacturing of biological preparations, and in the field of industrial biotechnology; Natural science services, namely, scientific research and medical research in the fields of bacteriological, fungal, chemical, bio-technical and pharmacological research services; Clinical research, namely, scientific research in the nature of conducting clinical trials for others; medical laboratories; conducting early evaluations in the field of new pharmaceuticals; Consultancy relating to pharmaceutical research and development; Drug discovery services

Publicações

Histórico de despachos e eventos da marca no USPTO.

24 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

29/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

29/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/03/2025

PUBO

PUBLISHED FOR OPPOSITION

11/03/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/03/2025

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

19/12/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

13/12/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

30/08/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

30/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

30/08/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/08/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

30/08/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

31/05/2024

GNFR

FINAL REFUSAL E-MAILED

31/05/2024

CNFR

FINAL REFUSAL WRITTEN

31/05/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/12/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/12/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/12/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

14/09/2023

GNRT

NON-FINAL ACTION E-MAILED

14/09/2023

CNRT

NON-FINAL ACTION WRITTEN

14/09/2023

DOCK

ASSIGNED TO EXAMINER

12/09/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

25/04/2023

NWAP

NEW APPLICATION ENTERED

04/04/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace OPENPICHIA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.